What is the ROE (Return on Equity) of Centogene this year?
The ROE of Centogene this year is 1.41 undefined.
Centogene ROE 2024
Centogene ROE
1.41
Ticker
CNTGF
ISIN
NL0014040206
WKN
A2PUCU
In 2024, Centogene's return on equity (ROE) was 1.41, a -132.66% increase from the -4.3 ROE in the previous year.
Centogene Aktienanalyse
What does Centogene do?
Centogene NV is a biotechnology company specializing in the research and diagnosis of rare genetic diseases. It was founded in 2006 by Arndt Rolfs and Christoph Lengauer in Rostock. The business model of Centogene NV is based on the application of genomic research and advanced technologies to develop novel diagnostic and therapeutic approaches. The company operates its own laboratories where DNA samples are analyzed and evaluated. The goal is to identify the genetic causes of rare diseases and provide patients with personalized treatment options. The company operates in several areas. One focus is on the diagnosis of rare diseases that have unclear genetic causes. The company offers a wide range of genetic tests that aim to enable fast and precise diagnosis. These include exome sequencing, RNA analysis, and gene panel tests. Another business field of Centogene NV is the development of new therapy approaches for rare diseases. The company collaborates with pharmaceutical companies and clinical researchers to develop innovative drugs and conduct clinical trials. The aim is to offer improved treatment options and enhance the quality of life for patients with rare diseases. Centogene NV is headquartered in Rostock, Germany, but also has offices in Lisbon, Portugal, Dubai, United Arab Emirates, and Boston, USA. The company operates globally and collaborates with medical centers and research laboratories worldwide. A special feature of Centogene NV is the CentoMD® database system. This is an extensive genetic database that contains clinical and genetic information from patients with rare diseases. This database is a valuable resource for diagnosis, research, and the development of new therapy approaches. The company works closely with patient groups and international organizations to raise awareness of rare diseases and create better treatment options. Centogene NV is also involved in the education and training of medical professionals to ensure better care for patients. Overall, Centogene NV is a leading company in the research and diagnosis of rare genetic diseases. The business model is based on the application of cutting-edge genomic research and technologies to provide patients with personalized treatment options. The company operates globally and has its own laboratories and extensive genetic database. Centogene NV is actively involved in research and education to improve the care of patients with rare diseases. Centogene ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Centogene's Return on Equity (ROE)
Centogene's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Centogene's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Centogene's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Centogene’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Centogene stock
How has the Return on Equity (ROE) of Centogene developed compared to the previous year?
The ROE of Centogene has increased by -132.66% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Centogene?
A high ROE indicates that Centogene generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Centogene?
A low ROE can indicate that Centogene is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Centogene affect the company?
A change in ROE (Return on Equity) of Centogene can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Centogene?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Centogene?
Some factors that can influence Centogene's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Centogene pay?
Over the past 12 months, Centogene paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Centogene is expected to pay a dividend of 0 EUR.
What is the dividend yield of Centogene?
The current dividend yield of Centogene is .
When does Centogene pay dividends?
Centogene pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Centogene?
Centogene paid dividends every year for the past 0 years.
What is the dividend of Centogene?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Centogene located?
Centogene is assigned to the 'Health' sector.
Wann musste ich die Aktien von Centogene kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Centogene from 10/2/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.
When did Centogene pay the last dividend?
The last dividend was paid out on 10/2/2024.
What was the dividend of Centogene in the year 2023?
In the year 2023, Centogene distributed 0 EUR as dividends.
In which currency does Centogene pay out the dividend?
The dividends of Centogene are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Centogene stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Centogene
Our stock analysis for Centogene Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Centogene Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.